News | April 19, 2021
Vaishali Pharma initiates 30 products registration
The company also plans to register the similar range of products in the neighbouring countries.
The company also plans to register the similar range of products in the neighbouring countries.
The promoter holding in the company has increased to 37.25%, a rise of 4.9% from 32.35% as of 31 March 2020
PEL will explore the PLI scheme and apply if its beneficial.
India business grew 11.8% YoY vs mid-single digit industry growth.
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
Subscribe To Our Newsletter & Stay Updated
